August 2020 FDA Recall Drug by Aurobindo Pharma Usa Inc.
D-1535-2020 - Presence of Foreign Substance

This Class II drug recall was voluntarily initiated by Aurobindo Pharma Usa Inc. on August 10, 2020 for the product Drug. The FDA reported the reason for recall as presence of foreign substance. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1535-2020

Reason for Recall
Presence of Foreign Substance: product complaints were received by the firm for the presence of metal wire in the tablet(s).
Initiated
08-10-2020
Reported
09-02-2020
Quantity
5748 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Aurobindo Pharma USA Inc.
Nationwide in the U.S.
Sulfamethoxazole and Trimethoprim Tablets, USP, 800 mg/160 mg Double Strength, 500 Tablets per bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC: 65862-420-05.

Batch or Lot Expiration Information

Lot# s: STSD19109-A, Exp. 05/31/2022; SP1D19083AA3, SP1D19084AA3, Exp. 08/31/2022.